FOS and carcinoma: As the protein extracts used in this study contained not only carcinoma cells, but also varying portions (<30%) of stromal fibroblasts, we performed immunohistochemistry with paraffin sections of 14 tumours to find out which cells are expressing the c-Fos protein.